Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bellicum Pharma Comm (NQ: BLCM )

4.170 USD -0.140 (-3.25%)
Official Closing Price Updated: 7:37 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bellicum Pharma Comm

< Previous 1 2 3 4 5 6 7 Next >
Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
From GlobeNewswire News Releases
Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
From GlobeNewswire News Releases
Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Bellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
From GlobeNewswire News Releases
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
From GlobeNewswire News Releases
Bellicum Announces Interim BPX-601 Data and Corporate Restructuring
From GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum to Participate in Two Upcoming Virtual Conferences
From GlobeNewswire News Releases
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
From GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum Reports Second Quarter 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum to Report Second Quarter 2020 Financial Results and Provide Corporate Update
Management to host webcast and conference call on Thursday, August 6, 2020 at 5 p.m. ET / 2 p.m. PT 
From GlobeNewswire News Releases
Bellicum Receives FDA IND Clearance to Initiate a Phase 1/2 Clinical Trial for BPX-603, a Dual-Switch GoCAR-T® for HER2+ Solid Tumors
From GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum Announces Publication of Data for GoCAR-NK™ Cell Program
From GlobeNewswire News Releases
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
From GlobeNewswire News Releases
Bellicum Reports First Quarter 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Rapha Capital Management Leads Series A Financing for FIZE Medical Inc.
FIZE's Novel Device Conquers the Last Frontier in Patient Monitoring 
From PR Newswire
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum Completes Sale of Houston Facility
From GlobeNewswire News Releases
Bellicum Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Bellicum to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update
Management to host webcast and conference call on Thursday, March 12, 2020 at 5 p.m. ET / 2 p.m. PT 
From GlobeNewswire News Releases
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum Announces Reverse Stock Split
From GlobeNewswire News Releases
Bellicum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Bellicum Presents New Translational Data for BPX-601 at ASCO GI Cancers Symposium
From GlobeNewswire News Releases
Bellicum Pharmaceuticals Enters into Asset Purchase and Master Services Agreements with MD Anderson
From GlobeNewswire News Releases
Bellicum Pharmaceuticals to Present New Translational Data for BPX-601 at ASCO 2020 Gastrointestinal Cancers Symposium
From GlobeNewswire News Releases
Bellicum Pharmaceuticals Licenses Its CaspaCIDe® Safety Switch to MD Anderson
Bellicum’s proprietary technology licensed for use in CD19 CAR NK program 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.